EMEA-002861-PIP02-20-M03
Table of contents
Key facts
Invented name |
Comirnaty
|
Active substance |
Tozinameran
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0547/2021
|
PIP number |
EMEA-002861-PIP02-20-M03
|
Pharmaceutical form(s) |
Concentrate for solution for injection
|
Condition(s) / indication(s) |
Prevention of Coronavirus disease 2019 (COVID-19)
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
BioNTech Manufacturing GmbH
Email: pediatric@biontech.de |
Decision type |
PM: decision on the application for modification of an agreed PIP
|